Monthly Archives: December 2015

Misleading Headlines About Misleading Advertising: “Dog” Fur Pom Poms on Hats

The headline of the story below is as misleading as the thing it’s criticizing. The hat “everyone is wearing” is not, in fact, made out of “dogs,” if by “dogs” you mean the canines that many of us have as

Misleading Headlines About Misleading Advertising: “Dog” Fur Pom Poms on Hats

The headline of the story below is as misleading as the thing it’s criticizing. The hat “everyone is wearing” is not, in fact, made out of “dogs,” if by “dogs” you mean the canines that many of us have as

Is Chipotle a(n Ethical) Lesson in Opportunity Cost?

Chipotle’s anti-GMO policies may win the burrito chain some customers, but those same policies take on a different ethical complexion when they are pursued to the apparent neglect of protecting customers from scientifically established – and potentially deadly – food-borne

Is Chipotle a(n Ethical) Lesson in Opportunity Cost?

Chipotle’s anti-GMO policies may win the burrito chain some customers, but those same policies take on a different ethical complexion when they are pursued to the apparent neglect of protecting customers from scientifically established – and potentially deadly – food-borne

Don’t Confuse Uber’s Impact With its Legal Status

Uber is bad for traditional taxi companies and for at least some drivers. And aspects of Uber’s operations skirt municipal regulations. But those two facts are basically unconnected. Uber is a disruptive technology, and jobs will be lost as a

Don’t Confuse Uber’s Impact With its Legal Status

Uber is bad for traditional taxi companies and for at least some drivers. And aspects of Uber’s operations skirt municipal regulations. But those two facts are basically unconnected. Uber is a disruptive technology, and jobs will be lost as a

Virtues in Business

Here’s a new paper on the popular-but-contested notion of “virtue”, in the latest issue of the Business Ethics Quarterly. >>> Virtuous Persons and Virtuous Actions in Business Ethics and Organizational Research, by Miguel Alzola Abstract: The language of virtue is

Virtues in Business

Here’s a new paper on the popular-but-contested notion of “virtue”, in the latest issue of the Business Ethics Quarterly. >>> Virtuous Persons and Virtuous Actions in Business Ethics and Organizational Research, by Miguel Alzola Abstract: The language of virtue is

A “Relational” Approach to Egalitarianism & Executive Compensation

A new paper by one of our favourite authors, in the latest issue of the Journal of Business Ethics. >>> Egalitarianism and Executive Compensation: A Relational Argument, by Pierre-Yves Néron Abstract: What, if anything, is wrong with high executive compensation?

A “Relational” Approach to Egalitarianism & Executive Compensation

A new paper by one of our favourite authors, in the latest issue of the Journal of Business Ethics. >>> Egalitarianism and Executive Compensation: A Relational Argument, by Pierre-Yves Néron Abstract: What, if anything, is wrong with high executive compensation?

HR Departments as Ethics Champions

What’s the role of HR departments in corporate ethics? The piece linked below suggests a dual role. First, HR is often the “home” for ethics policies (e.g., codes of ethics) and ethics training. Secondly, HR is the source of a

HR Departments as Ethics Champions

What’s the role of HR departments in corporate ethics? The piece linked below suggests a dual role. First, HR is often the “home” for ethics policies (e.g., codes of ethics) and ethics training. Secondly, HR is the source of a

Martin Shkreli, Stock Manipulation: Victimless Crimes (or Crimeless Victims?)

This looks more or less like a victimless crime. Turing Pharamaceuticals CEO Martin Shkreli is in the news again. This time, it’s because of his activity in the stock market. Basically, he bought up controlling shares in a dying drug

Martin Shkreli, Stock Manipulation: Victimless Crimes (or Crimeless Victims?)

This looks more or less like a victimless crime. Turing Pharamaceuticals CEO Martin Shkreli is in the news again. This time, it’s because of his activity in the stock market. Basically, he bought up controlling shares in a dying drug